TPI Business and Development Profile Updated on OneMedDatabase
CHENGDU, China, April 4, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI ), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals has updated its corporate business & development information on OneMedDatabase, a division of OneMedPlace, a New York-based healthcare research and business & development firm.
The profile is to serve as a portal for TPI in the development of partnership with U.S. as well as international pharmaceutical companies for the further growth expansion via TPI's in-depth coverage of pharmaceutical sales network in China and TPI's upcoming macrolide antibiotic API business.
The updated profile of TPI along with an interview with the management can be found via the following link: http://www.onemedplace.com/database/list/cid/14315 
OneMedPlace (OMP), based in New York, is a healthcare research company that manages a business development platform to help emerging healthcare and life sciences companies maximize their potentials. OMP provides companies and investors with efficient access to information about potential opportunities around the world through an integrated set of tools including:
OneMedDatabase : Over 8,000 companies and resources.
OneMedForum : a biannual business development and investment conferences in San Francisco (January) and New York City (June).
OneMedTV : Documentaries on promising companies and technologies and important healthcare events.